People: BioSphere Medical Inc (BSMD.O)
2.68USD
9 Feb 2010
$-0.06 (-2.37%)
$2.74
$2.41
$2.78
$2.41
28,943
77,665
$4.19
$1.26
Hennemann, Willard
Brief Biography
Mr. Hennemann, Ph.D. has served as Vice President, New Product and Business Development of BioSphere Medical, Inc. since February 2008. From 2006 to early 2008, Dr. Hennemann served as Vice President of Intravascular Systems/Marketing for Medeikon Corporation, an early-stage developer of proprietary disposable technologies to treat cardiovascular disease. From 2000 to 2006, Dr. Hennemann held the position of Vice President of Research and Development/Interventional Vascular at CryoCath Technologies, a leader in catheter-based products for the cryotherapeutic treatment of cardiovascular disease. From 1998 to 1999, Dr. Hennemann served as Director of Marketing and Product Development for Intervascular (a division of Datascope), which produces a broad line of vascular grafts. From 1996 to 1998, Dr. Hennemann served as Director of Marketing/International Clinical Studies of the Global Stent Business Unit for Medtronic, Inc., a medical technology company. Prior to Medtronic, Dr. Hennemann assumed roles of increasing responsibility over a 12-year period with Cordis Corporation, a pioneer in developing innovative diagnostic and therapeutic devices for interventional vascular medicine. Dr. Hennemann received his B.A. from the University of Maryland and a Ph.D. from the University of Florida.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 176,923 | -- | 81,386 | 258,309 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
| Southwell, David | -- |
| Faleschini, Richard | 1,155,270 |
| Joyce, Martin | 596,974 |
| Weinstein, Joel | 353,074 |
| Sutcliffe, Peter | 428,460 |
| Domurad, Melodie | 313,808 |





